The Jury Is Still Out

Affiliations

Comment

Peter Lansbury. Mov Disord. 2022 Mar.

. 2022 Mar;37(3):651.

doi: 10.1002/mds.28911. Epub 2022 Jan 17.

No abstract available

Comment in

Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Mov Disord. 2022 Mar;37(3):651-652. doi: 10.1002/mds.28929. Epub 2022 Jan 22. Mov Disord. 2022. PMID: 35064687 No abstract available.

Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Mov Disord. 2022 Jan;37(1):190-195. doi: 10.1002/mds.28792. Epub 2021 Sep 22. Mov Disord. 2022. PMID: 34550621 Free PMC article.

1. Omer N, Giladi N, Gurevich T, et al. Glucocerebrosidase activity is not associated with Parkinson's disease risk or severity. Mov Disord 2022;37(3):651-652.
1. Davis MY, Johnson CO, Leverenz JB, et al. Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease. JAMA Neurol 2016;73(10):1217-1224.
1. Maple-Grodem J, Dalen I, Tysnes OB, et al. Association of GBA genotype with Motor and Functional Decline in patients with newly diagnosed Parkinson Disease. Neurology 2021;97(17):e1036-44.
1. Ortega RA, Wang C, Raymond D, et al. Association of dual LRRK2 and GBA variations with Parkinson disease progression. JAMA Netw Open 2021;4(4):e215845.
1. Weely V, van den Berg M, Barranger JA, Sa Miranda MC, Tager JM, Aerts JM. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease. J Clin Invest 1993;91:1167-1175.